This article first appeared on Ohio Capital Journal

Buried in a March executive order from President Donald Trump is a provision that could cast doubt on voting machines in Ohio and around the country. The order directs federal officials to amend a set of security benchmarks for voting machines.

We’re under assault in every direction without a safe space in sight. Don’t make the mistake of thinking that I’m referring to street crime or border crossings, both of which have been plummeting. I’m talking about our ability to believe what we see or hear. I’m talking about our ability to absorb what we read and believe that we are dealing with fact-based truths that are objective, nonpartisan, and, even real. The evidence is overwhelming and the intent is pervasive.

No small part of this lies with the White House. Trump is transparent about his interests in this regard:

Thursday, August 14
 6:00 PM
WSYX, 1261 Dublin Rd, Columbus, OH 43215

In the last 18 months, over 200 journalists have been killed in Gaza while risking everything to tell the truth.

Around the world, journalists speak out when one of their own is killed—yet ABC6, FOX28, CW Columbus, and their parent companies have stayed silent. This silence fuels impunity and erases the lives of those who paid the ultimate price for press freedom.

On Thursday, August 14, we will gather outside their shared Columbus location to remember these journalists, honor their courage, and demand that our local media break their silence.

Bring banners, and your voice. Let’s show that their lives—and their work—will not be forgotten.

Bridgett Brown, a resident of California, developed breast cancer from using brand-name and generic versions of the antipsychotics Risperdal (risperidone) and Zyprexa (olanzapine) says a bold new lawsuit from the Wisner Baum law firm.

Neither Brown or her two prescribing physicians knew or “had reason to know” that the drugs could cause breast cancer since the drug manufacturers “obfuscated and disclaimed such risks while promoting these dangerous, expensive drugs over safer, more affordable alternatives.”

Brown suffered disfigurement, physical injury, pain and emotional distress and demands a jury trial, says the suit. Drug giants Johnson & Johnson or J&J (who marketed Risperdal) and Eli Lilly (who marketed Zyprexa) are among the suit’s major defendants along with J&J subsidiary Janssen Pharmaceuticals (who marketed Risperdal) and Lilly German partner Cheplapharm Arzneimittel Gmbh.

Off-Label Prescriptions Versus Off-Label Marketing